Eric Guenzi
About
Eric Guenzi is a scholar working on Immunology, Molecular Biology and Pediatrics, Perinatology and Child Health.
According to data from OpenAlex, Eric Guenzi has authored 27 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 7 papers in Molecular Biology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Eric Guenzi's work include Biosimilars and Bioanalytical Methods (7 papers), Pneumonia and Respiratory Infections (5 papers) and Pharmaceutical studies and practices (5 papers). Eric Guenzi is often cited by papers focused on Biosimilars and Bioanalytical Methods (7 papers), Pneumonia and Respiratory Infections (5 papers) and Pharmaceutical studies and practices (5 papers). Eric Guenzi collaborates with scholars based in Germany, United States and Italy. Eric Guenzi's co-authors include Regine Hakenbeck, Michel Sicard, Ingeborg Grgurina, Guido Grandi, G. Galli, Dennis C. Gross, Geneviève Alloing, Miguel Cámara, Odile Humbert and Bernard Martin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
In The Last Decade
Eric Guenzi
27 papers receiving 1.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Eric Guenzi Germany | 16 | 616 | 501 | 396 | 294 | 208 | 27 | 1.8k | ||
| Zhongtian Qi China | 27 | 1.2k 1.9× | 599 1.2× | 422 1.1× | 413 1.4× | 190 0.9× | 136 | 2.6k | ||
| Caroline J. Barelle United Kingdom | 20 | 929 1.5× | 577 1.2× | 290 0.7× | 71 0.2× | 202 1.0× | 42 | 1.8k | ||
| Bertrand Bellier France | 21 | 322 0.5× | 338 0.7× | 631 1.6× | 200 0.7× | 219 1.1× | 47 | 1.4k | ||
| Yoshio Yamakawa Japan | 26 | 1.3k 2.1× | 226 0.5× | 323 0.8× | 321 1.1× | 117 0.6× | 91 | 2.3k | ||
| Enza Piccolella Italy | 28 | 446 0.7× | 417 0.8× | 1.3k 3.2× | 220 0.7× | 211 1.0× | 77 | 2.1k | ||
| Claude Auriault France | 25 | 359 0.6× | 310 0.6× | 540 1.4× | 78 0.3× | 191 0.9× | 71 | 1.6k | ||
| Guerino Lombardi Italy | 21 | 473 0.8× | 319 0.6× | 216 0.5× | 282 1.0× | 59 0.3× | 60 | 2.0k | ||
| Mary C. Graves United States | 18 | 935 1.5× | 294 0.6× | 437 1.1× | 287 1.0× | 182 0.9× | 33 | 2.2k | ||
| Sven Burgdorf Germany | 25 | 1.3k 2.1× | 321 0.6× | 2.3k 5.7× | 114 0.4× | 390 1.9× | 42 | 3.6k |
Countries citing papers authored by Eric Guenzi
Since
Specialization
Citations
This map shows the geographic impact of Eric Guenzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Guenzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Guenzi more than expected).
Fields of papers citing papers by Eric Guenzi
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Eric Guenzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Guenzi. The network helps show where Eric Guenzi may publish in the future.
Co-authorship network of co-authors of Eric Guenzi
This figure shows the co-authorship network connecting the top 25 collaborators of Eric Guenzi. A scholar is included among the top collaborators of Eric Guenzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Guenzi. Eric Guenzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Richter, Kathleen, et al.. (2023). Ex vivo comparative immunogenicity assessment (EVCIA) to determine relative immunogenicity in chronic plaque psoriasis in participants receiving Humira® or undergoing repeated switches between Humira® and AVT02. PubMed. 4(1). ltad029–ltad029.
2.
Berti, Fausto, et al.. (2022). Joint analysis of PK and immunogenicity outcomes using factorization model − a powerful approach for PK similarity study. BMC Medical Research Methodology. 22(1). 264–264.
3.
Damjanov, Nemanja, et al.. (2022). Assessment of real-life patient handling experience of AVT02 administered subcutaneously via autoinjector in patients with moderate to severe active rheumatoid arthritis: an open-label, single-arm clinical trial, then an extension phase of AVT02 administered with a prefilled syringe. Expert Opinion on Biological Therapy. 23(8). 781–789.
4.
Guenzi, Eric, et al.. (2022). AB1586-PARE MULTI-CENTER, RANDOMIZED, OPEN-LABEL, 2-ARM PARALLEL STUDY TO COMPARE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF AVT02 ADMINISTERED SUBCUTANEOUSLY VIA PREFILLED SYRINGE OR AUTOINJECTOR IN HEALTHY ADULT VOLUNTEERS. Annals of the Rheumatic Diseases. 81. 1891–1892.
5.
Feldman, Steven R., Grażyna Pulka, Külli Kingo, et al.. (2021). Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study. BioDrugs. 35(6). 735–748.
6.
Dong, Yun, Roman Fischer, Petrus J.W. Naudé, et al.. (2016). Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration. Proceedings of the National Academy of Sciences. 113(43). 12304–12309.
7.
Richter, Fabian, Eric Guenzi, Andreas Herrmann, et al.. (2013). Antagonistic TNF Receptor One-Specific Antibody (ATROSAB): Receptor Binding and In Vitro Bioactivity. PLoS ONE. 8(8). e72156–e72156.
8.
Hua, Jing, Nikolai Gross, B. Schulze, et al.. (2012). In vivo imaging of choroidal angiogenesis using fluorescence-labeled cationic liposomes.. PubMed. 18. 1045–54.
9.
Herber-Jonat, Susanne, et al.. (2010). Comparison of lung accumulation of cationic liposomes in normal rats and LPS-treated rats. Inflammation Research. 60(3). 245–253.
10.
Eichhorn, Martin, Ivan Ischenko, Sebastian Strieth, et al.. (2009). Vascular targeting by EndoTAG™‐1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer. International Journal of Cancer. 126(5). 1235–1245.
11.
Grubert, Thomas, Thomas W. Grimm, Eric Guenzi, et al.. (2005). Maternal HIV Type 1 Infection Suppresses MMP-1 Expression in Endothelial Cells of Uninfected Newborns: Nonviral Vertical Transmission of HIV Type 1-Related Effects. AIDS Research and Human Retroviruses. 21(11). 940–944.
12.
Guenzi, Eric. (2003). The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression. The EMBO Journal. 22(15). 3772–3782.
13.
Lubeseder–Martellato, Clara, Eric Guenzi, Elisabeth Naschberger, et al.. (2002). Guanylate-Binding Protein-1 Expression Is Selectively Induced by Inflammatory Cytokines and Is an Activation Marker of Endothelial Cells during Inflammatory Diseases. American Journal Of Pathology. 161(5). 1749–1759.
14.
Guenzi, Eric. (2001). The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. The EMBO Journal. 20(20). 5568–5577.
15.
Guenzi, Eric, et al.. (1998). Coordinate Transcription and Physical Linkage of Domains in Surfactin Synthetase Are Not Essential for Proper Assembly and Activity of the Multienzyme Complex. Journal of Biological Chemistry. 273(23). 14403–14410.
16.
Guenzi, Eric, G. Galli, Ingeborg Grgurina, Dennis C. Gross, & Guido Grandi. (1998). Characterization of the Syringomycin Synthetase Gene Cluster. Journal of Biological Chemistry. 273(49). 32857–32863.
17.
Zähner, Dorothea, Thorsten Grebe, Eric Guenzi, et al.. (1996). Resistance Determinants for β-Lactam Antibiotics in Laboratory Mutants of Streptococcus pneumoniae That Are Involved in Genetic Competence. Microbial Drug Resistance. 2(2). 187–191.
18.
Rosa, Domenico, Susanna Campagnoli, Cristiane Moretto, et al.. (1996). A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.. Proceedings of the National Academy of Sciences. 93(5). 1759–1763.
19.
Guenzi, Eric, et al.. (1994). A two‐component signal‐transducing system is involved in competence and penicillin susceptibility in laboratory mutants of Streptococcus pneumoniae. Molecular Microbiology. 12(3). 505–515.
20.
Martin, Bernard, Odile Humbert, Miguel Cámara, et al.. (1992). A highly conserved repeated DNA element located in the chromosome ofStreptococcus pneumoniae. Nucleic Acids Research. 20(13). 3479–3483.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Zhongtian Qi Breakdown of academic impact, for papers by Caroline J. Barelle Breakdown of academic impact, for papers by Bertrand Bellier Breakdown of academic impact, for papers by Yoshio Yamakawa Breakdown of academic impact, for papers by Enza Piccolella Breakdown of academic impact, for papers by Claude Auriault Breakdown of academic impact, for papers by Guerino Lombardi Breakdown of academic impact, for papers by Mary C. Graves Breakdown of academic impact, for papers by Sven Burgdorf